Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JB.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.7.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.30.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.68NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.43.6 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.43.9 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XUNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.3 (Omicron)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.16.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.372NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.251NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.256NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.77NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.248NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.70NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.559NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.406NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.69NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ER.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.640NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.256NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Q.7 (Alpha)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.460NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.262NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBUNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.351.5 (Beta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FZ.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used